Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05897710
Other study ID # 22-011357
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date September 1, 2024
Est. completion date September 1, 2028

Study information

Verified date February 2024
Source Mayo Clinic
Contact LaPrincess C Brewer, MD, MPH
Phone 507-538-2517
Email Brewer.LaPrincess@mayo.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The proposed trial is a multiphase, multicenter, non-inferiority, hybrid type 1 effectiveness, randomized controlled trial to test an innovative virtual world-based cardiac rehabilitation (CR) program, "Destination Cardiac Rehab". The primary objectives of this study are to assess the efficacy and adherence of "Destination Cardiac Rehab" compared to traditional center-based CR.


Description:

The proposed virtual world-based cardiac rehabilitation (VWCR) program provides a novel home-based delivery method of a CR program to address several barriers to care associated with traditional center-based CR (CBCR). This 2-arm, randomized controlled trial (RCT) will rigorously assess adherence and efficacy of VWCR compared to CBCR in a 12-week (36-session) intervention that includes patient education, self-monitoring of physical activity and blood pressure, social support, and weekly telehealth visits with a CR nurse and exercise physiologist. Patients with a CR eligible cardiovascular event will be recruited from 6 geographically diverse CR centers across the United States. We hypothesize that the VWCR, known as "Destination Cardiac Rehab" will be non-inferior to CBCR as assessed by improvement in cardiovascular health and adherence to CR sessions.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 150
Est. completion date September 1, 2028
Est. primary completion date September 1, 2027
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Indication for CR according to Centers for Medicare & Medicaid Services (CMS) guidelines: Myocardial infarction within the preceding 12 months; Coronary artery bypass surgery; Current stable angina (chest pain); Heart valve repair or replacement; Percutaneous transluminal coronary angioplasty (PTCA) or coronary stenting; Heart or heart-lung transplant; Stable chronic heart failure - Aged =18 years - Basic Internet navigation skills - Active email address Exclusion Criteria: - High risk patients according to the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) risk stratification (e.g., sudden cardiac arrest survivor) - Receiving continuous inotropic support - Presence of a mechanical circulatory support device - Decompensated heart failure - Symptomatic valvular heart disease - Uncontrolled angina - Presence of hemodynamically unstable dysrhythmias (e.g., ventricular tachycardia) given safety concern of unsupervised exercise20 - Pregnant (due to associated hormonal and weight changes) - Non-English-speaking - Visual/hearing impairment or mental disability that would preclude independent use of the VW platform

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Virtual World-Based Cardiac Rehabilitation (VWCR)
12-week virtual world technology-based program via Second Life platform. Weekly virtual visits with nurse coach and exercise physiologist, weekly education sessions, and social support group discussions within the virtual world environment.
Center-Based Cardiac Rehabilitation (CBCR)
Traditional 12-week in-person cardiac rehabilitation program; standard of care at participant's cardiac rehabilitation facility

Locations

Country Name City State
United States Mayo Clinic Rochester Minnesota

Sponsors (4)

Lead Sponsor Collaborator
Mayo Clinic Johns Hopkins University, University of California, Irvine, University of Mississippi Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Life's Essential 8 component: Self-reported healthy diet Changes from baseline in healthy diet using the Mediterranean Eating Patterns for Americans (MEPA), a 16-item questionnaire evaluating accordance with a Mediterranean-like diet pattern Baseline, 3 months, and 6 months post-randomization
Primary Life's Essential 8 component: Self-reported physical activity Changes from baseline in physical activity using the International Physical Activity Questionnaire (IPAQ), a 12-item questionnaire classifying physical activity as "low," "moderate," or "high" intensity physical activity (minutes/day) over the prior week Baseline, 3 months, and 6 months post-randomization
Primary Life's Essential 8 component: Self-Reported smoking status Changes from baseline in smoking status using the National Health and Nutrition Examination Survey-Smoking-Cigarette Use Questionnaire (NHANES-SMQ), evaluating current and past smoking habits Baseline, 3 months, and 6 months post-randomization
Primary Life's Essential 8 component: Sleep Quality Changes from baseline in sleep quality (number of hours of sleep nightly) using the Pittsburg Sleep Quality Index (PSQI). Baseline, 3 months, and 6 months post-randomization
Primary Life's Essential 8 component: Body Mass Index (BMI) Changes from baseline in BMI as calculated with weight (kg) and height (m), reported as kg/m^2 Baseline, 3 months, and 6 months post-randomization
Primary Life's Essential 8 component: Cholesterol Changes from baseline in Non-HDL Cholesterol levels reported as mg/dL Baseline, 3 months, and 6 months post-randomization
Primary Life's Essential 8 component: Blood Glucose Changes from baseline in Hemoglobin A1c (percent) and fasting blood glucose (mg/dL) Baseline, 3 months, and 6 months post-randomization
Primary Life's Essential 8 component: Blood Pressure Changes from baseline in systolic and diastolic blood pressure measurements; average of three sitting readings in mmHg Baseline, 3 months, and 6 months post-randomization
Primary Life's Essential 8 composite score: Cardiovascular health Changes from baseline in Life's Essential 8 score. Life's Essential 8 composite score is determined as a composite of all components by calculating an unweighted average score on a scale of 0 to 100 points. An overall cardiovascular health score (Life's Essential 8 score) will be considered high (80 to 100 points), moderate (50 to 79 points) or low for (0 to 49 points). Baseline, 3 months, and 6 months post-randomization
Primary Number of sessions attended by participants Optimal adherence defined as completion of 70% or more of weekly visits (in-person or virtual). Attendance measured by CR staff for control group, and by VWCR web administrators, Exercise Physiologists, and Nurse Coaches in the VWCR arm. Baseline through 12-week program
Secondary MACE (Major Adverse Cardiovascular Events) 3 months post-randomization MACE (Major Adverse Cardiovascular Events): CV-related hospital readmissions; CV and all-cause mortality 3 months and 6 months post-randomization
Secondary Exercise Sessions Self-reported number of self-directed exercise sessions per week, confirmed by Fitbit activity tracker data. Baseline through 12-week (36 session) cardiac rehabilitation program
Secondary Functional Capacity Six-Minute walk test, evaluating blood pressure, oxygen saturation, and pulse after walking for 6 minutes at a normal pace Baseline, 3 months, and 6 months post-randomization
Secondary Health-related quality of life Changes from baseline in health-related quality of life using the Short Form [SF]-12 Health Survey, a self-reported outcome measure assessing the impact of health on an individual's everyday life. The SF-12 consists of 12-items and 8 subdomains. Each item of the questionnaire has response categories which vary from 2- to 6-point scales and raw scores for items ranging from 1 to 6. The raw scores are summated and linearly transformed into 0-100 scale with a higher score indicating better health status. Baseline, 3 months, and 6 months post-randomization
Secondary Physical Activity Self-efficacy Changes from baseline in physical activity self-efficacy measured by the Exercise Confidence Survey scale to assess the participant's confidence in their ability to exercise when faced with common barriers. 12 items are assessed, each on a 5-point scale ranging from 1 to 5. A higher total sum indicates higher self-efficacy for physical activity. Baseline, 3 months, and 6 months post-randomization
Secondary Physical Activity Self-regulation Changes from baseline in physical activity self-regulation measured by the Health Beliefs Survey to assess strategies used in the past 3 months to increase their step count or physical activity levels. Items are measured on a five-point scale from 1 (never) to 5 (repeatedly). Higher scores indicate more self-regulation. Baseline, 3 months, and 6 months post-randomization
Secondary Physical Activity Social Support Changes from baseline in physical activity social support using the Social Support for Exercise Survey scale that asks participants how much encouragement they received to increase physical activity on a five-point scale from 1 (never) to 5 (very often). Higher scores indicate more social support for physical activity. Baseline, 3 months, and 6 months post-randomization
Secondary Diet Self-efficacy Changes from baseline in diet self-efficacy measured the Diet Confidence Survey scale to assess the participant's confidence in their ability to maintain a healthy diet when faced with common barriers. 12 items are assessed, each on a 5-point scale ranging from 1 to 5. A higher total sum indicates higher self-efficacy for healthy eating. Baseline, 3 months, and 6 months post-randomization
Secondary Diet Self-regulation Changes from baseline in diet self-regulation measured by the Health Beliefs Survey to assess strategies used in the past 3 months to eat healthier foods. Items are measured on a five-point scale from 1 (never) to 5 (repeatedly). Higher scores indicate more use of self-regulation strategies to promote healthy eating. Baseline, 3 months, and 6 months post-randomization
Secondary Diet Social Support Changes from baseline in diet social support using the Social Support for Eating Habits Survey scale that asks participants how much encouragement they received to eat healthier on a five-point scale from 1 (never) to 5 (very often). Higher scores indicate more social support for healthy eating. Baseline, 3 months, and 6 months post-randomization
See also
  Status Clinical Trial Phase
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT04056208 - Pistachios Blood Sugar Control, Heart and Gut Health Phase 2
Recruiting NCT04417387 - The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
Not yet recruiting NCT06211361 - Cardiac Rehabilitation Program in Patients With Cardiovascular Disease N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04514445 - The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
Enrolling by invitation NCT04253054 - Chinese Multi-provincial Cohort Study-Beijing Project
Completed NCT03273972 - INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers N/A
Completed NCT03680638 - The Effect of Antioxidants on Skin Blood Flow During Local Heating Phase 1
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Completed NCT04083846 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) Phase 1
Completed NCT04083872 - Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) Phase 1
Completed NCT03619148 - The Incidence of Respiratory Symptoms Associated With the Use of HFNO N/A
Completed NCT03693365 - Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
Completed NCT03466333 - Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia Phase 2
Completed NCT04082585 - Total Health Improvement Program Research Project
Completed NCT05132998 - Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)